首页> 外国专利> isolated antibody, composition, isolated nucleic acid molecule, vector, host cell, method for producing an antibody, hybridoma, methods for alleviating one or more symptoms of disease, and for decreasing or inhibiting hlight binding to man, ltbr, dcr3 or any combination thereof, and to decrease or inhibit the secretion of ccl20, il-8, rantes or any combination thereof, and, kit

isolated antibody, composition, isolated nucleic acid molecule, vector, host cell, method for producing an antibody, hybridoma, methods for alleviating one or more symptoms of disease, and for decreasing or inhibiting hlight binding to man, ltbr, dcr3 or any combination thereof, and to decrease or inhibit the secretion of ccl20, il-8, rantes or any combination thereof, and, kit

机译:分离的抗体,组合物,分离的核酸分子,载体,宿主细胞,产生抗体的方法,杂交瘤,减轻一种或多种疾病症状,以及减少或抑制人与人,ltbr,dcr3或其任何组合的结合的方法,以及减少或抑制ccl20,il-8,蚁或其任何组合的分泌的试剂盒

摘要

isolated antibody, composition, isolated nucleic acid molecule, vector, host cell, method for producing an antibody, hybridoma, use of a composition, methods to decrease or inhibit the binding of hlight to man, ltbetar, dcr3 or any combination thereof, and to decrease or inhibit the secretion of ccl20, il-8, rants or any combination thereof, and antibodies, such as fully human antibodies, are provided herein that immunospecifically bind to a hlight polypeptide. isolated nucleic acids encoding antibodies, such as fully human antibodies, which immunospecifically bind to a hlight polypeptide are also provided. in addition, vectors and host cells are provided which comprise nucleic acids encoding antibodies, such as fully human antibodies, which immunospecifically bind to a hlight polypeptide. methods of making antibodies, such as fully human antibodies, that immunospecifically bind to a hlight polypeptide are also provided. also provided herein is a method of treating a hlight-mediated disease in a patient which comprises administering to the patient an antibody, such as a fully human antibody, which immunospecifically binds to a hlight polypeptide. In preferred embodiments, these anti-HIV antibodies hlight provided herein will improve, neutralize or otherwise inhibit the biological activity of hlight in vivo (e.g., hcl-mediated production or secretion of ccl20, il-8 or rant from a cell expressing a hlight receptor). also provided here is a method for detecting hlight in a sample as well as a method to improve, neutralize or otherwise inhibit hlight activity, for example, in a human patient suffering from a disorder in which hlight activity it's harmful.
机译:分离的抗体,组合物,分离的核酸分子,载体,宿主细胞,产生抗体的方法,杂交瘤,组合物的用途,减少或抑制人类与人类,ltbetar,dcr3或其任何组合的结合的方法,以及减少或抑制ccl20,il-8,ants或其任何组合的分泌,并且本文提供了免疫特异性结合hlight多肽的抗体,例如完全人抗体。还提供了分离的核酸,其编码免疫特异性结合于hlight多肽的抗体,例如完全人抗体。另外,提供了载体和宿主细胞,其包含编码抗体的核酸,所述核酸例如完全人源抗体,其免疫特异性地结合至hlight多肽。还提供了制备与hlight多肽免疫特异性结合的抗体,例如完全人抗体的方法。本文还提供了一种治疗患者的由hlight介导的疾病的方法,该方法包括向该患者施用与该hlight多肽免疫特异性结合的抗体,例如全人抗体。在优选的实施方案中,本文提供的这些抗HIV抗体hlight将改善,中和或以其他方式抑制体内hlight的生物学活性(例如,hcl介导的从表达hlight受体的细胞产生ccl20,il-8或ant的分泌或分泌)。 )。本文还提供了一种检测样品中白光的方法,以及改善,中和或以其他方式抑制白光活性的方法,例如,在患有白光活动有害的疾病的人类患者中。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号